Palantir’s stock draws a downgrade over its ‘gluttonous valuation’
An analyst thinks Palantir will see AI benefits but deems the stock’s valuation to be steep on a relative basis and given industry pressures.
An analyst thinks Palantir will see AI benefits but deems the stock’s valuation to be steep on a relative basis and given industry pressures.
The offering is aimed at boosting liquidity and paying down part of a $2 billion revolving-credit facility.
“Just because market value is transferring quickly, doesn’t make it wrong,” an analyst says.
‘Active-adult’ communities are attracting younger buyers who are looking closer to home
What Pamela Teaster really wants to be is a paramedic, and she’ll think about retirement when she hits triple digits.
Oil futures ticked lower Friday, but remained on track for solid weekly gains as investors gauged the potential for a wider Middle Eastern conflict that could endanger crude flows from the region.
CarMax reported lower sales, but the company is encouraged by more affordable prices.
Sarapeta Therapeutics Inc.’s stock soared 38% in premarket trade Friday, after the biotech said the U.S. regulator has approved an expanded indication of its treatment for the rare muscle disorder Duchenne muscular dystrophy.
Treasury yields were falling on Friday, as investors looked ahead to existing home sales and other data.
As veterans retire, freshly minted advisers in their 20s and 30s are replacing them.
Tech-savvy Gen Z consumers are forcing retailers to adapt to their digital life.
Morgan Stanley’s Michael Mauboussin has cultivated a loyal following over his nearly four decades on Wall Street. He joined MarketWatch for a brief interview earlier this week.
Short positions in popular assets are at record lows, implying a bet that volatility will stay low.
Justin Trudeau has faced pressure to match the positions of the U.S. and European Union by hiking tariffs on imported Chinese EVs
“Is this jealousy or a change in perceived status that has upended her friendships? Any ideas or cures?”
The British company which sells J2O said it had rejected Carlsberg’s offer to acquire it for 1,250 pence per share
Sydney Sweeney is on a red-hot streak with her real estate purchases, and this one is surrounded by water and palm trees.
Zealand Pharma said a second trial of patients on a higher dosage of its weight-loss drug showed an 8.6% drop in body weight.
Japan’s overall consumer inflation grew at a faster pace in May and stayed well above the Bank of Japan’s 2% target.
U.K. consumer confidence improved slightly in June on improved assessment of the economy, as inflation eases and ahead of national elections, a monthly survey said.